Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation

Pure red cell aplasia (PRCA) following allogeneic hematopoietic stem cell transplantation (HSCT) has been mostly reported in situations involving major ABO incompatibility between donor and recipient. Conventional treatments such as plasma exchange, erythropoietin, and steroid are often unsatisfacto...

詳細記述

書誌詳細

主要な著者:	Sung-Hoon Jung, Jae-Sook Ahn, Deok-Hwan Yang, Hyung Chul Park, Soo-Young Bae, Yeo-Kyeoung Kim, Hyeoung-Joon Kim, Je-Jung Lee
フォーマット:	Artigo
言語:	Inglês
出版事項:	Karger Publishers 2012-02-01
シリーズ:	Case Reports in Oncology
主題:	Rituximab ABO compatibility Pure red cell aplasia Allogeneic stem cell transplantation
オンライン･アクセス:	http://www.karger.com/Article/FullText/337022
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!